BlueBird Bio Drug Might Get Accelerated OK In U.S., Europe By: Benzinga via Benzinga May 19, 2015 at 14:31 PM EDT Bluebird Bio Inc(NASDAQ: BLUE) fluttered up Tuesday on news that approvals for its LentiGlobin for treating a rare blood ... Read More >> Related Stocks: Bluebird Bio